Fidrisertib Succinate
N/A
Report date: 2026/04/25 20:00:23
NME
Base Information
Drug NameFidrisertib Succinate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[15]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBlueprint Medicines CorpIpsen SA
China Registration ClassN/A
Develop Information
Active CompaniesBlueprint Medicines Corp
Inactive CompaniesIpsenClementia Pharmaceuticals IncCatalent Nottingham Ltd +[4]
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A